Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|May 11, 2012
Phase II study of sorafenib in patients with relapsed or refractory lymphomaAnna Guidetti, Carmelo Carlo-Stella, Silvia L Locatelli, et al.
Blood|August 3, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLLLydia Scarfò, Silvia Heltai, Elisa Albi, et al.
Blood|March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availabilityBarbara Sarina, Luca Castagna, Lucia Farina, et al.
Hematological Oncology|March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in ItalyFrancesco Autore, Andrea Visentin, Candida Vitale, et al.
Hematological Oncology|July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategySimonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Haematologica|July 22, 2021
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcomeAnna Dodero, Anna Guidetti, Fabrizio Marino, et al.
American Journal of Hematology|August 6, 2019
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) networkMarzia Varettoni, Emanuela Boveri, Silvia Zibellini, et al.
Hematological Oncology|February 7, 2019
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical networkSara Rattotti, Virginia Valeria Ferretti, Chiara Rusconi, et al.
Annals of Hematology|March 13, 2025
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian studyAlessia Castellino, Lorenzo Comba, Laura Bertolotti, et al.
Hematological Oncology|March 19, 2021
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working GroupGian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, et al.
Pageof 6